GO:0018394 peptidyl-lysine acetylation: Mechanism & Genes

Peptidyl-lysine acetylation (GO:0018394) is a fundamental post-translational modification in which an acetyl group is covalently attached to the epsilon-amino group of a lysine residue in a protein or peptide. This process is conserved across all domains of life and serves as a central regulatory mechanism for protein function, affecting enzymatic activity, protein-protein interactions, subcellular localization, and stability. In bacteria, lysine acetylation is increasingly recognized as a key player in metabolic regulation and stress responses, including antibiotic resistance and anaerobic respiration. For researchers, understanding peptidyl-lysine acetylation is critical because it provides a molecular explanation for how cells dynamically adjust their physiology in response to environmental cues. The modification is reversible and tightly controlled by acetyltransferases and deacetylases, as well as by metabolic intermediates such as acetyl-phosphate. In Escherichia coli, acetylation of specific lysine residues on the NarL protein (K188 and K192) directly modulates anaerobic nitrate respiration, illustrating how a single acetylation event can rewire a complex regulatory circuit. Similarly, global studies have linked lysine acetylation to antibiotic resistance pathways, suggesting that this modification is a potential target for overcoming drug resistance. Given its broad impact, peptidyl-lysine acetylation is a focal point for both basic and translational research, and CRISPR-based models are indispensable for pinpointing the exact lysine residues that drive these phenotypes.

According to the Gene Ontology, peptidyl-lysine acetylation (GO:0018394) is defined as the acetylation of peptidyl-lysine. In other words, it is the biochemical process in which an acetyl group is added to a lysine residue that is part of a peptide chain, typically on the side-chain amino group. This definition encompasses both enzymatic and non-enzymatic acetylation events and is a subclass of protein acetylation. The term is used to annotate gene products that catalyze or regulate this modification, as well as the targets that undergo it.

Peptidyl-lysine acetylation is important because it is a pervasive regulatory modification that controls protein function in virtually every cellular compartment and organism. In bacteria, it influences virulence, metabolism, and antibiotic resistance, while in eukaryotes it regulates transcription, DNA repair, and signal transduction. The modification can act as a molecular switch, and its dysregulation is associated with diseases such as cancer and neurodegeneration. Understanding the enzymes and target sites involved is therefore essential for developing therapeutic strategies that modulate acetylation.

The following genes and proteins are central to peptidyl-lysine acetylation, either as writers, erasers, or targets of the modification, based on experimental evidence in bacteria and other systems.

Peptidyl-lysine acetylation is regulated at multiple levels. The availability of acetyl-CoA and acetyl-phosphate directly influences the rate of acetylation, linking this modification to central metabolism. Enzymatic regulation by acetyltransferases and deacetylases provides specificity and reversibility. In E. coli, the acetylation state of NarL is controlled by the opposing activities of these enzymes, and mutations at K188 and K192 alter anaerobic nitrate respiration, demonstrating that site-specific regulation is critical for physiological function. Additionally, environmental factors such as oxygen levels and antibiotic exposure can shift the acetylation landscape, suggesting that this process is integrated into global stress responses.

Lysine acetylation has been implicated in the antibiotic resistance of Escherichia coli, where acetylation of specific proteins may alter drug targets or activate resistance pathways. This connection suggests that targeting acetylation enzymes could restore antibiotic sensitivity, making peptidyl-lysine acetylation a potential therapeutic target.

Because acetylation regulates key metabolic enzymes and virulence factors in bacteria, dysregulation of this process can affect the outcome of infections and metabolic disorders. Understanding how acetylation of proteins like NarL influences anaerobic respiration may provide insights into bacterial survival in host tissues.

In eukaryotes, aberrant lysine acetylation is associated with cancer and neurodegenerative diseases, where it affects gene expression and protein aggregation. Although the provided citations focus on bacterial systems, the fundamental principles of acetylation are conserved, and bacterial models can inform drug discovery for these human conditions.

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) coupled with acetyl-lysine enrichment is the primary method for identifying acetylated proteins and mapping specific lysine sites. This approach has been used to characterize the acetylome of E. coli and to link acetylation to antibiotic resistance.

To test the causal role of a specific lysine, researchers generate point mutations (e.g., K-to-R to block acetylation or K-to-Q to mimic acetylation) using CRISPR or classical mutagenesis. Such experiments have demonstrated that NarL K188 and K192 acetylation is required for proper regulation of anaerobic nitrate respiration.

Anaerobic growth assays, nitrate reduction tests, and minimal inhibitory concentration (MIC) measurements are used to assess the functional consequences of altered acetylation. These assays link molecular modifications to whole-cell phenotypes.

Large-scale proteomic datasets are analyzed with bioinformatics tools to identify enriched pathways and networks among acetylated proteins. This systems-level view helps prioritize targets for further study and reveals crosstalk with other post-translational modifications.

Researchers studying peptidyl-lysine acetylation-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as antibiotic resistance or metabolic regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of acetylation writers, erasers, and target sites.

Peptidyl-lysine acetylation (GO:0018394) is a central post-translational modification that regulates protein function across all domains of life. In bacteria, it controls critical processes such as anaerobic respiration and antibiotic resistance, as exemplified by NarL acetylation in E. coli. Understanding the enzymes, target sites, and regulatory networks involved requires precise genetic models, and CRISPR-based approaches are indispensable for this task. By leveraging EDITGENE's services, researchers can accelerate discoveries in this dynamic field and uncover new therapeutic opportunities.